Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growing research and development activities and financial support by various private and government organizations for cannabinoid research
4.2.2 Rising occurrence of chronic diseases and related complications
4.2.3 Legalization of marijuana in various regions
4.3 Restraints
4.3.1 Adverse effects associated with Cannabis
4.3.2 Stringent government policies
4.4 Opportunities
4.4.1 Improving status of cannabis in Asian countries
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Monitoring
5.2 Porter's Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Investment Opportunity Analysis
5.4 Pricing Analysis
6 Global Hemp Based Products Market, By Region
6.1 Key Overview:
6.2 Global Overview
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Rest of the World (ROW)
6.7 Global Hemp Based Products Market , by Industrial Application
6.8 Hemp CBD Product, By Type
6.9 Global Hemp Based Products Market, By Consumption Data
6.1 Global Hemp CBD Product Type (Volume sales)
6.10.1 Historical data:
6.10.2 Forecasted data:
7 Global CBD Oil Market, by Product
7.1 Introduction
7.1.1 Marijuana-derived CBD Oil
7.1.2 Hemp-derived CBD Oil
8 Global CBD Oil Market, by Application
8.1 Introduction
8.1.1 Pain Relief
8.1.2 Neurological Disorders
8.1.3 Fibromyalgia
8.1.4 Mood Disorders
8.1.5 Diabetes
9 Global CBD Oil Market, by Distribution Channel
9.1 Introduction
9.1.1 E-Commerce Websites
9.1.2 Retail Pharmacies
9.1.3 Medical Marijuana Dispensaries
9.1.4 Hospital Pharmacies
10 Global CBD Oil Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 UK
10.3.1.3 France
10.3.1.4 Spain
10.3.1.5 Italy
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 Australia
10.4.4 India
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Rest of the World
11 Competitive Landscape
11.1 Competitive Landscape
12 Company Profile
12.1 Aurora Cannabis
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products/Services Offered
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategy
12.2 Canopy Growth Corporation
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products/Services Offered
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategy
12.3 CBD American Shaman
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products/Services Offered
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategy
12.4 CV Sciences Inc.
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products/Services Offered
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.4.6 Key Strategy
12.5 Elixinol Global Limited
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products/Services Offered
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategy
12.6 ENDOCA
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products/Services Offered
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategy
12.7 Bluebird Botanicals LTD
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products/Services Offered
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategy
12.8 IrieCBD
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products/Services Offered
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategy
12.9 Isodiol International Inc.
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products/Services Offered
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategy
12.1 Medical Marijuana Inc
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products/Services Offered
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategy
13 Appendix
13.1 Discussion Blue Print